495 related articles for article (PubMed ID: 15120735)
1. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
2. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
5. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
[TBL] [Abstract][Full Text] [Related]
6. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
Chazan B; Raz R; Edelstein H; Kennes Y; Gal V; Colodner R
Microb Drug Resist; 2015 Oct; 21(5):551-5. PubMed ID: 26430943
[TBL] [Abstract][Full Text] [Related]
8. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
Cohen R
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
[TBL] [Abstract][Full Text] [Related]
9. Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish children.
Ciftçi E; Dogru U; Güriz H; Aysev D; Ince E
Pediatr Int; 2002 Dec; 44(6):647-51. PubMed ID: 12421263
[TBL] [Abstract][Full Text] [Related]
10. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
Zavadska D; Bērziņa D; Drukaļska L; Pugacova N; Miklasevics E; Gardovska D
APMIS; 2010 May; 118(5):366-70. PubMed ID: 20477812
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
[TBL] [Abstract][Full Text] [Related]
13. [Penicillin tolerance in group A beta-hemolytic streptococci isolated from throat cultures of children with tonsillopharyngitis].
Ciftçi E; Doğru U; Güriz H; Aysev AD; Ince E
Mikrobiyol Bul; 2002 Apr; 36(2):147-52. PubMed ID: 12652866
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Jakob-Sölder B; Steininger C; Eigentler A; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):811-2. PubMed ID: 9923529
[No Abstract] [Full Text] [Related]
16. [Streptococcal pharyngitis].
Romero J; Betriu C
Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):611-27. PubMed ID: 8808478
[No Abstract] [Full Text] [Related]
17. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Norrby SR; Quinn J; Rangaraju M; Leroy B
Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin-resistant group A streptococci.
Linder JA; Stafford RS
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
[No Abstract] [Full Text] [Related]
19. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
[TBL] [Abstract][Full Text] [Related]
20. [Pharyngeal A-streptococcal infection encountered in the practical work of an internal medicine specialist].
Belov BS
Vestn Otorinolaringol; 2013; (3):39-43. PubMed ID: 23887373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
